What is CAP?

Founded in 1993, the Corporate AACE Partnership (CAP) is a forum whose purpose is to develop and nurture an open dialogue between industry and our association to advance patient care. The mission of the CAP is to facilitate the improvement of endocrine patient care by working with industry in areas of mutual interest.
Current Partners
Abbott Diabetes Care
AbbVie
Amarin Pharma Inc.
Amgen
AstraZeneca
Bigfoot Biomedical
Boehringer Ingelheim Pharmaceuticals, Inc.
Corcept Therapeutics
Dexcom, Inc.
Health Monitor Network
Horizon Therapeutics
Insulet Corporation
Intarcia Therapeutics, Inc.
Janssen
Lexicon Pharmaceuticals
Lilly Diabetes
Mannkind Corporation
Medtronic, Inc
Merck-Pfizer Diabetes Collaboration
Novo Nordisk
Pfizer
PhRMA
Quest Diagnostics
Radius Health
Sandoz
Sanofi
Strongbridge Biophama
Takeda Pharmaceuticals U.S.A, Inc.
Xeris Pharmaceuticals
To learn more about the CAP or to request more details about joining the CAP, e-mail [email protected].